Stocks | | | Earnings season is upon us and U.S. equity markets can provide bountiful trading opportunities for those who put in the “work”. Seasoned traders understand there are four Super Bowls a year for volatility, momentum and liquidity and that is earnings season. The real work entails maintain... Read the Full Story |
|
From Our Partners | | How to Collect Up To $5,917/mo From Trump's Made In USA Boom
Thanks to President Trump's America-First policies, a historic wave of investment is flooding back into the United States: Apple committing a colossal $500 billion to build new U.S. factories. Microsoft injecting $80 billion into domestic manufacturing. Nvidia moving critical chip production back to America.
But here's the hidden opportunity: There's now a groundbreaking way for you to start collecting monthly checks from these very same companies— checks that could reach as high as $5,917 each month.
Don't miss your chance to participate directly in America's industrial comeback. | | Watch Now to Learn How to Get Your First Check in 30 Days |
|
Stocks | | | The rural farmlands of the agriculture industry are closely tied to Wall Street. With almost 7 billion people in the world to feed, the agricultural industry has become highly advanced over the years, giving investors a great windfall in the form of growing stock values and dividends. Read the Full Story |
|
Stocks | | | Earnings season inevitably provides a plethora of stocks that react with gappers and dumpers. Gappers are stocks that gap up on results and dumpers are stocks that gap down on results. We will review the key gapper patterns that can be traded intraday. It’s important to remember to focus on th... Read the Full Story |
|
From Our Partners | Most traders guess. This system doesn’t.
Using his Momentum Indicator, one trader turned $15K into $150K in six months — stacking 20–30% daily gains. Now he’s sharing 3 stocks flashing BUY right now, plus a free report showing how to trade them. | | Claim your 3 stock picks + free momentum trading report |
|
Markets | | | You might wonder what the presence or lack of female executives has to do with Wall Street and deciding which stocks to buy. But while the role of gender equality in any given industry might not be part of an investor’s typical process of fundamental analysis, it cannot be ignored that an increasing number of women are closing the gender gap with men to hold CEO positions. Read the Full Story |
|
Markets | | | Trying to forecast stock price targets is a perpetual work in progress. Whether using quantitative valuation models, fundamental research or technical analysis, the goal is always to try to answer a simple question, “Where is the stock price going?” Read the Full Story |
|
From Our Partners | | New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun.
Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation. | | See Altucher’s Trump crypto prediction here |
|
The Early Bird Stock Of The Day Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Its lead product candidate NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase I clinical trial to treat opioid use disorder, or OUD; and in preclinical trial for the treatment of alcohol use disorder, or AUD. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois. | | View Today's Stock Pick |
|
